At Michael Fishman MD, we are dedicated to staying at the forefront of innovation in pain management. Recently, several groundbreaking studies on Differential Target Multiplexed (DTM™) Spinal Cord Stimulation (SCS) have been published, providing valuable insights into its applications and benefits for patients experiencing chronic pain.
Here’s a summary of the latest research, along with links to the open-access articles for further exploration.
- NOVA Randomized Controlled Trial (RCT)
Study Focus:
This study examined the efficacy of DTM™ SCS compared to conventional SCS in patients with chronic refractory axial low back pain who are not candidates for spine surgery. Conditions included degenerative disc disease, herniated disc, and radicular pain syndrome.
Key Findings:
The 12-month results demonstrated that DTM™ SCS provides significant improvements over conventional SCS in managing chronic low back pain.
Citation:
White T, Justiz R, Almonte W, et al. 12-Month Results from a Randomized Controlled Trial Comparing Differential Target Multiplexed Spinal Cord Stimulation and Conventional Spinal Cord Stimulation in Subjects with Chronic Refractory Axial Low Back Pain not Eligible for Spine Surgery. North American Spine Society Journal (NASSJ). 2024:100528.
Link:
Read the full study
- PROCURA Study: DTM™ SCS for Upper Limb Pain
Study Focus:
The PROCURA study evaluated DTM™ SCS for managing chronic intractable upper limb pain.
Key Findings:
After 12 months, DTM™ SCS was shown to be effective in reducing pain and improving quality of life for patients suffering from upper limb pain.
Citation:
White T, Justiz R, Fishman M, et al. Differential Target Multiplexed Spinal Cord Stimulation for the Treatment of Chronic Intractable Upper Limb Pain: 12-Month Results From a Prospective, Multicenter Study. Neuromodulation. 2024 Jul 24:S1094-7159(24)00628-7. doi: 10.1016/j.neurom.2024.06.497.
Link:
Read the full study
- Cost-Effectiveness Analysis of DTM™ SCS in the UK
Study Focus:
This study analyzed the cost-effectiveness of DTM™ SCS in the UK, focusing on its value in managing chronic pain conditions.
Key Findings:
The analysis concluded that DTM™ SCS is a cost-effective solution for patients, balancing clinical efficacy with economic benefits.
Citation:
Gulve A, Mehta V, Provenzano DA, et al. Differential Target Multiplexed Spinal Cord Stimulation: A UK Cost-Effectiveness Analysis. Neuromodulation. 2024 Jul;27(5):908-915. doi: 10.1016/j.neurom.2024.02.009.
Link:
Read the full study
These studies highlight the transformative potential of DTM™ SCS in pain management, offering hope and improved outcomes for patients. For more information or to discuss how these advancements may benefit you or your practice, please reach out to our office.
Stay informed, stay empowered.